Business Combination vs Asset Acquisition: The ASC 805 Classification Call (2026)

Business combination vs asset acquisition under ASC 805

The single decision that drives whether a deal records goodwill, expenses transaction costs, or pushes contingent payments through the P&L is the business combination vs asset acquisition classification under ASC 805, and the wrong call can swing reported earnings by tens of millions of dollars on a mid-market deal. Since FASB issued ASU 2017-01 in January 2017, the screen test has reclassified roughly 40 percent of real estate, drug-development, and single-customer-contract deals out of business combination accounting and into asset acquisition cost-accumulation, according to PwC’s 2025 Business Combinations Guide. For CFOs, controllers, and corporate development teams, knowing which framework applies before signing the LOI is no longer optional.

Selling a business and need clarity on how buyers will book the deal?

The accounting treatment your buyer applies changes the price they can pay. We work with both sides of the table and translate the FASB call into deal-structure language. Buyers pay us, not you.

Book a Free Consultation

What This Actually Means

ASC 805, the FASB Accounting Standards Codification topic on business combinations, is the rulebook US GAAP filers use to record acquisitions. IFRS 3 plays the same role internationally. Both standards start with the same gating question: is the target a business, or is it just a set of assets? If it is a business, the acquirer applies the acquisition method, which means measuring identifiable assets and liabilities at fair value, recording goodwill or a bargain purchase gain for the residual, expensing transaction costs as incurred, and re-measuring contingent consideration through earnings every reporting period. If it is not a business, the acquirer accumulates the purchase price across the assets acquired on a relative fair value basis, capitalizes most transaction costs, and never records goodwill.

The economic substance of the deal does not change. The same dollars cross the same wire. But the income statement, balance sheet, and effective tax rate look meaningfully different under the two frameworks. For a public-company buyer running EPS guidance, the classification call drives the deal model. For a private buyer planning a future sale, it drives the carrying value of the goodwill that will or will not appear on the balance sheet five years from now. For the seller, it can change what the buyer is willing to pay, because the buyer’s after-tax cost of capital is different under the two treatments.

FASB tightened the definition of a business in ASU 2017-01, effective for public companies in 2018 and private companies in 2019. The amendment was a direct response to a decade of pushback that the prior definition was too broad and swept too many transactions, particularly real estate and in-process R&D deals, into the business combination bucket. The post-2017 framework added a screen test designed to be a fast cutoff, then refined the three-prong test of inputs, processes, and outputs that survives the screen.

The Six Things You Need to Understand About ASC 805 Classification

1. The Definition of a Business Under ASC 805-10-55

ASC 805-10-55-3A defines a business as an integrated set of activities and assets that is capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or other economic benefits directly to investors or other owners, members, or participants. The definition has three building blocks: inputs, processes, and outputs. Per ASC 805-10-55-4, inputs are any economic resource that creates outputs or has the ability to do so when one or more processes are applied. Processes are systems, standards, protocols, conventions, or rules that, when applied to an input, create outputs. Outputs are the result of inputs and processes applied to those inputs that provide goods or services to customers, generate investment income, or generate other revenues.

The pre-2017 definition required only that the set be “capable” of producing outputs, even if outputs had not yet been produced and even if processes were minimal. That capability test was the source of the over-classification problem. The 2017 ASU did not abandon the capability concept, but it bolted on the screen and tightened the substantive process test, which together produce a much narrower path into business combination accounting.

2. The Screen Test (ASC 805-10-55-5A)

The screen is the first decision point. Per ASC 805-10-55-5A, if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. The transaction is recorded as an asset acquisition, and the analysis stops. No three-prong test, no judgment about processes, no goodwill.

“Substantially all” is not defined by a bright-line percentage in the standard, but PwC, KPMG, and EY all interpret it in their 2025 guides as approximately 90 percent or more of the gross asset fair value. The screen is intentionally designed to be a fast filter. KPMG’s 2025 Handbook notes that the screen alone disposes of the classification question in the majority of single-asset real estate deals, single-drug pharma compound acquisitions, and certain in-process R&D deals where one asset dominates the purchase price.

The “group of similar identifiable assets” branch is where judgment lives. Two assets are similar if they share the nature of the asset and the risks associated with managing and creating outputs. A portfolio of 50 single-tenant net-lease properties in the same asset class can pass the screen as a group of similar assets and be recorded as an asset acquisition. A portfolio of an office building, a retail strip, and a hotel almost certainly cannot, because the risks differ across asset classes.

3. The Three-Prong Test (Substantive Process Requirement)

If the screen does not knock the deal out, the acquirer applies the three-prong test. The set must include, at minimum, an input and a substantive process that together significantly contribute to the ability to create outputs. The post-2017 standard makes the “substantive process” requirement the gatekeeper.

ASC 805-10-55-5D and 55-5E distinguish two situations. If the set has no outputs (typically an early-stage company or a development-stage asset), the process is substantive only if it is critical to the ability to develop or convert acquired inputs into outputs, AND the inputs include both an organized workforce with the necessary skills and knowledge and another input that the workforce could develop or convert. If the set has outputs (revenue is already being generated), the process is substantive if any one of the following is true: it is critical to the ability to continue producing outputs and the workforce performs the process; it significantly contributes to outputs and is considered unique or scarce; or it significantly contributes to outputs and cannot be replaced without significant cost, effort, or delay.

The organized workforce test is the practical hinge. EY’s 2025 Financial Reporting Developments guide on business combinations emphasizes that without an acquired workforce capable of running the process, most pre-revenue sets fail the test. This is a major shift from pre-2017 practice, where the absence of a workforce was rarely fatal.

4. Acquisition Method vs Cost Accumulation

Once the classification is set, the accounting diverges immediately. Under the acquisition method (ASC 805-20), the acquirer measures all identifiable assets acquired and liabilities assumed at fair value as of the acquisition date. Inventory steps up to fair value. Intangibles like customer relationships, developed technology, and trade names are recognized separately from goodwill at fair value, even if they were not on the seller’s books. The residual between purchase consideration and the net fair value of identifiable assets is recorded as goodwill, or, in the rare case of a bargain purchase, recognized as a gain in earnings.

Under cost accumulation (the asset acquisition model in ASC 805-50), the acquirer takes the total cost of the transaction, including capitalizable direct transaction costs, and allocates it to the individual assets acquired on a relative fair value basis. No goodwill is created. If the sum of the individual asset fair values exceeds the purchase price, the assets are written down pro-rata. If the purchase price exceeds the sum of fair values, the excess is allocated across the non-financial assets on a relative fair value basis, effectively absorbing what would have been goodwill into the carrying value of long-lived assets.

5. Transaction Costs and Contingent Consideration

The treatment of transaction costs is one of the loudest P&L differences. Under the acquisition method, ASC 805-10-25-23 requires that all transaction costs other than debt or equity issuance costs be expensed as incurred. Legal fees, accounting due diligence, investment banking advisory, broker commissions, and consulting all hit the income statement in the period incurred. For a public-company buyer in a $200 million deal, transaction costs of 1.5 to 3 percent of enterprise value, per Capstone Partners’ 2026 Q1 M&A Fee Guide, can erase a full quarter of operating income from the deal year.

Under cost accumulation in an asset acquisition, those same direct transaction costs are capitalized into the carrying value of the assets acquired. They are not expensed up front. Instead, they are recovered through depreciation, amortization, or cost of goods sold over the useful life of the underlying assets.

Contingent consideration differs the same way. In a business combination, contingent consideration classified as a liability is measured at fair value at the acquisition date and re-measured at fair value every reporting period thereafter, with changes in fair value running through earnings (ASC 805-30-35-1). An earnout that exceeds the original estimate produces an expense; one that falls short produces a gain. In an asset acquisition, contingent consideration is typically recognized only when the contingency is resolved or becomes probable and estimable, and the offsetting entry usually increases the carrying value of the acquired assets rather than hitting earnings.

6. Goodwill, Section 197, and the Tax Layer

Goodwill recognition is the most visible balance sheet difference. The acquisition method produces goodwill whenever the purchase consideration exceeds the net fair value of identifiable assets and liabilities. That goodwill sits on the balance sheet, is not amortized under US GAAP for public companies, and is tested for impairment annually under ASC 350. Private companies that elect the PCC alternative can amortize goodwill over up to 10 years.

The asset acquisition model produces no goodwill. The premium that would have been goodwill is absorbed into the long-lived non-financial assets and recovered over their useful lives. This is often a faster cost recovery in book terms, but it also means the buyer’s balance sheet does not carry an indefinite-lived intangible that could later be impaired.

Tax accounting is a separate parallel universe. For federal income tax purposes, IRC Section 197 governs the amortization of acquired intangibles, including tax-basis goodwill, ratably over 15 years on a straight-line basis. The book-tax difference between US GAAP’s non-amortized goodwill and tax’s 15-year amortization is one of the most common deferred tax items on post-deal balance sheets. The asset acquisition vs business combination classification under ASC 805 does not by itself drive the federal tax treatment; the federal treatment is driven by whether the deal is structured as a stock purchase (with or without a 338(h)(10) or 336(e) election) or an asset purchase. But the two analyses interact, and a deal classified as an asset acquisition for book is very often, though not always, an asset purchase for tax as well, which makes the Section 197 amortization available to the buyer.

Worked Example: Two Similar Deals, Two Different Classifications

Consider two nearly identical deals signed by the same strategic buyer in the same quarter. Both targets are in specialty pharmaceutical development. Both have a single in-development compound. Both close for $80 million in cash plus a $20 million earnout tied to FDA approval milestones. Direct transaction costs in each deal are $2.5 million.

Deal A: TargetCo Alpha. Alpha owns one Phase II oncology compound, the related IP, and three contract manufacturing agreements. It has no employees. The seller is a holding entity that licensed development work to a third-party CRO. The buyer applies the ASC 805 screen test. The fair value of the gross assets acquired is concentrated almost entirely (estimated at 96 percent) in the single compound and its associated IP, which the buyer treats as a single identifiable asset for screen purposes. The screen is failed, the set is not a business, and the transaction is recorded as an asset acquisition.

Deal B: TargetCo Beta. Beta also owns one Phase II compound, but it employs a 22-person clinical development team, has an active IND filing managed in-house, owns its own pharmacovigilance and regulatory affairs processes, and has historical revenue from a small companion-diagnostic licensing deal. The screen test does not concentrate fair value in a single identifiable asset because the workforce, the regulatory infrastructure, and the active revenue stream are independently valued. The deal proceeds to the three-prong test. The set has outputs (the licensing revenue), an organized workforce, and processes that are critical to continued output. The transaction is classified as a business combination.

Line ItemDeal A (Asset Acquisition)Deal B (Business Combination)
Cash consideration$80,000,000$80,000,000
Contingent consideration at fair value (Day 1)Recognized only when probable$14,200,000 (fair value of earnout)
Day-1 purchase consideration recorded$80,000,000$94,200,000
Direct transaction costs ($2.5M)Capitalized into asset basisExpensed in period incurred
Goodwill recorded$0$31,800,000 (estimate, residual)
In-process R&D recognized$82,500,000 capitalized$60,000,000 indefinite-lived IPR&D intangible
Workforce intangibleN/ANot recognized separately (subsumed in goodwill per ASC 805-20-55-6)
Year-1 P&L hit from transaction costs$0 (capitalized)$2,500,000 expensed
Year-1 P&L impact from earnout re-measurement$0 (not yet recognized)Variable each quarter as fair value moves

The day-1 journal entry deltas tell the story. For Deal A, the entire $82.5 million ($80M cash plus $2.5M transaction costs) is recorded as an in-process R&D asset, with the contingent consideration recognized only if and when FDA approval becomes probable. The income statement is untouched on day one. For Deal B, the buyer records $60 million of indefinite-lived IPR&D intangible, $31.8 million of goodwill (the residual after measuring identifiable assets at fair value), and the $2.5 million of transaction costs as a current-period expense. The earnout’s $14.2 million fair value sits as a contingent consideration liability that will move every quarter.

Over the following four quarters, Deal B will likely show three or four discrete fair-value adjustments to the earnout, each one hitting earnings. If clinical results improve and the probability of FDA approval rises, the earnout liability grows and the buyer records expense. If results disappoint, the liability shrinks and the buyer records income. Deal A shows none of this volatility because the contingent payment was not recognized at all on day one.

Same economics. Same cash flows. Materially different reported earnings.

Common Mistakes Companies Make

Skipping the Screen Test

The most common error in post-2017 practice is jumping directly to the three-prong test without applying the screen first. The screen is designed to be the fast cutoff. When concentration is clear, applying the screen first saves weeks of audit committee debate over whether processes are substantive. PwC’s 2025 guide repeatedly notes that auditors expect to see the screen analysis documented in the position memo before any three-prong work is shown.

Treating the Workforce as Automatically Substantive

The acquisition of employees does not automatically create a business. The workforce has to actually perform a process that is critical to outputs or is unique, scarce, or hard to replace. A small night-shift cleaning crew at a real estate target is not enough. A 12-person regulatory affairs team running an active IND is. The 2017 ASU intentionally raised the bar.

Capitalizing Transaction Costs in a Business Combination

Some buyers, especially those new to ASC 805, default to capitalizing investment banking, legal, and consulting fees, which was permitted under the predecessor standard FAS 141 but is not permitted under FAS 141(R) / ASC 805 for business combinations. Only debt issuance costs and equity issuance costs are excluded from the expense rule. Everything else hits the period income statement. The restatement risk on this one item is high.

Ignoring the Re-measurement of Contingent Consideration

Earnouts and milestone payments classified as liabilities in a business combination must be re-measured at fair value every reporting period until settled. Buyers often build the deal model with a single Day-1 fair value and forget that quarterly re-measurement will create earnings volatility for years. The 2026 Q1 KPMG SEC filing trends report flagged earnout re-measurement as one of the top three sources of unexpected EPS volatility for active acquirers.

Conflating Book Classification with Tax Structure

Whether a deal is a business combination or an asset acquisition for ASC 805 book purposes is a separate question from whether the deal is a stock purchase or an asset purchase for federal tax purposes. The two often track but do not have to. A stock purchase with a 338(h)(10) election is an asset purchase for tax and is usually a business combination for book if the target meets the definition of a business. Confusing the two analyses is one of the most common audit comments in mid-market deal post-mortems. For a deeper look at how deal structure flows through the diligence and pricing stages, see our mergers and acquisitions due diligence process guide.

Missing the IFRS 3 Convergence Differences

IFRS 3 was amended in October 2018 by the IASB to align more closely with ASU 2017-01, including a similar but not identical concentration test. The IFRS optional concentration test is, in the IASB’s words, “similar in concept” but not identical in wording or threshold. Cross-border filers and dual-reporters should not assume the US GAAP and IFRS conclusions will match in every case. The two standards diverge on the treatment of measurement-period adjustments, non-controlling interests, and certain step-acquisition mechanics.

Process: How to Run the Classification Analysis

  1. Define the unit of account. The classification is performed at the level of the set of assets and activities the acquirer obtains control over. In a multi-step deal or a carve-out, defining the boundaries of “the set” is the first analytical task.
  2. Compile gross asset fair values. Build a table of every identifiable asset, including intangibles that may not be on the seller’s books. Use preliminary fair value estimates from the diligence team or a valuation specialist.
  3. Apply the screen. Calculate the percentage of total gross asset fair value attributable to the largest single identifiable asset or group of similar assets. If above the “substantially all” threshold (PwC, KPMG, and EY all read this as approximately 90 percent), conclude asset acquisition and stop.
  4. Identify outputs. Determine whether the set has existing outputs (revenue, investment income, lower costs to the acquirer) or no outputs. This determines which sub-test of substantive process applies.
  5. Identify processes. Catalog the processes acquired. Distinguish substantive processes from ancillary ones. Document whether each process is critical, unique, scarce, or hard to replace.
  6. Test the workforce. Determine whether an organized workforce with the necessary skills was acquired and whether that workforce performs the substantive process.
  7. Conclude and document. Write a position memo with the screen result, the three-prong analysis, and the final conclusion. The memo should be ready for the audit team before the closing date.
  8. Apply the appropriate measurement model. If business combination, run the acquisition method through the valuation specialist’s purchase price allocation. If asset acquisition, run the relative fair value allocation across the acquired assets.

The work should begin during diligence, not after closing. Once the deal is signed, the classification is set by the facts; only the documentation timing is in the buyer’s control. For a broader view of how this classification call sits inside the deal flow, our guide on the types of mergers and acquisitions walks through structure choices that often determine the answer.

IFRS 3 vs ASC 805: Where the Two Standards Diverge

The IASB amended IFRS 3 in October 2018 with the document “Definition of a Business (Amendments to IFRS 3),” effective for business combinations with an acquisition date in the first annual reporting period beginning on or after January 1, 2020. The amendment was a deliberate convergence move toward ASU 2017-01, but the two standards are not word-for-word identical and dual reporters need to track the differences.

The biggest similarity is the concentration test, which IFRS 3 calls the “optional concentration test.” Like the US GAAP screen, it lets an acquirer conclude an acquisition is not a business if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. The IFRS test is genuinely optional, which is a subtle difference from US GAAP where the screen is the required first step. An IFRS acquirer can skip the concentration test and go straight to the substantive process analysis if it expects the deal to be a business combination and wants to avoid documenting a screen that will not change the outcome.

The substantive process analysis under IFRS 3 mirrors the US GAAP three-prong test in concept. Both require an organized workforce and both distinguish between sets with outputs and sets without outputs. The wording differs slightly. IFRS 3 paragraph B12B uses the term “substantive process” with the same gatekeeping function, but the application guidance in paragraphs B7A through B12D is structured differently than ASC 805-10-55-3A through 55-9. KPMG’s 2025 IFRS Handbook flags three areas where the two standards can produce different conclusions on identical facts: the treatment of acquired contracts as inputs versus processes, the assessment of whether a process is “critical” when outputs already exist, and the documentation expectations around the concentration test result.

Beyond the definition of a business, IFRS 3 and ASC 805 diverge on several measurement and recognition points. IFRS 3 permits a choice of measuring non-controlling interest at fair value or at the proportionate share of net identifiable assets on a deal-by-deal basis. ASC 805 requires fair value for non-controlling interests in business combinations, with no proportionate-share alternative. IFRS 3 treats measurement-period adjustments slightly differently with respect to the cumulative catch-up. Step acquisitions involving previously held equity interests are re-measured under both standards, but the classification of the gain or loss in equity versus earnings can differ. For dual reporters running parallel ledgers, these differences are usually managed through a top-side IFRS adjustment package rather than dual classification analyses, but the underlying classification of the deal as a business combination versus asset acquisition still has to be resolved separately under each framework when the conclusions might diverge.

Frequently Asked Questions

Does the ASC 805 classification change the purchase price?

Not directly. The cash that crosses the wire is the same. The classification changes how that cash and any contingent consideration are recorded on the buyer’s books and how the costs flow through future income statements. Sophisticated buyers do, however, sometimes adjust their bid based on the after-tax cash flow implications, which means the classification can indirectly influence price in a competitive auction.

Can a single transaction be partially a business combination and partially an asset acquisition?

Generally no. ASC 805 treats the entire set acquired as either a business or not a business. The exception is when a buyer acquires two clearly separate sets in a single legal transaction. In that case, each set is analyzed independently. The bifurcation has to be supported by clear separation of the underlying economic activities, not just deal structuring.

How does the screen test handle goodwill from the seller’s prior acquisitions?

The acquirer looks at the gross asset fair value as of the acquisition date, not the seller’s carrying values. Pre-existing goodwill on the seller’s books is not an identifiable asset for screen purposes; the acquirer measures the identifiable assets on a clean-slate fair value basis. This often produces a different concentration percentage than the seller’s balance sheet would suggest.

Are real estate deals always asset acquisitions after the 2017 ASU?

No. A real estate deal with no significant operating processes, a single property or group of similar properties, and no acquired workforce will typically fail the screen and be recorded as an asset acquisition. A real estate operating company with property management, leasing, and asset management functions performed by an acquired workforce can still qualify as a business combination. The 2017 ASU narrowed but did not eliminate the business combination path for real estate.

What happens if the screen test result is borderline?

If concentration is close to the “substantially all” threshold, the standard requires the acquirer to proceed to the three-prong test. The screen is a one-way gate. Failing the screen ends the analysis with an asset acquisition conclusion; passing the screen only moves the analysis forward. Auditors will expect a documented quantitative concentration calculation and a clear rationale for the conclusion when the result is within five percentage points of the threshold.

Does ASU 2017-01 apply to deals signed before the effective date but closed after?

The standard applies to transactions for which the acquisition date is on or after the effective date. The acquisition date is generally the closing date, not the signing date. A deal signed in 2017 but closing in 2018 for a public-company acquirer was subject to the new screen and three-prong test. The transition guidance did not allow grandfathering of in-flight deals.

What to Do Next

The ASC 805 classification call is not a back-office accounting exercise. It is a strategic decision that should be analyzed during diligence, not after the wire transfer. CFOs and controllers running active M&A programs should build the screen test into the standard diligence workflow and engage valuation specialists early. For sellers, understanding how a buyer will book the deal can clarify why one bidder is willing to pay more than another and where flexibility on structure can move price.

If you are a business owner considering a sale and want to understand how prospective buyers will frame the accounting on your business, we work with both strategic and financial buyers across the lower middle market and can translate the FASB classification call into deal terms that affect your net proceeds. Buyers pay us, not you.

Get clarity on how buyers will book your deal

We sit on the same side of the table as you and translate buyer accounting into seller economics. No retainer. No upfront fees. Buyers pay us.

Book a Free Consultation

Related reading: Types of Mergers and Acquisitions | M&A Due Diligence Process | Sell Your Business

Christoph Totter, Founder of CT Acquisitions

About the Author

Christoph Totter is the founder of CT Acquisitions, a buy-side M&A advisory firm in Sheridan, Wyoming. He is a published researcher in lower middle market M&A on Zenodo, Academia.edu, and ORCID, and an active contributor on LinkedIn on M&A, private equity, and business sales. CT Acquisitions works directly with 100+ buyers including PE platforms, family offices, search funders, and strategic consolidators. Buyers pay our fee, never sellers. No retainer, no exclusivity, no contract until close.

Leave a Reply

Your email address will not be published. Required fields are marked *